Neuroglia Health Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 30.46%
(FY 2023)
- Profit 42.09%
(FY 2023)
- Ebitda 41.04%
(FY 2023)
- Net Worth 60.35%
(FY 2023)
- Total Assets 44.87%
(FY 2023)
About Neuroglia Health
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Eiji Tsuchiya, Kazutaka Kanairo, and Vineet Bagri serve as directors at the Company.
- CIN/LLPIN
U85110KA2015FTC079978
- Company No.
079978
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
28 Apr 2015
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Neuroglia Health?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vineet Bagri  | Director | 24-Mar-2023 | Current |
Eiji Tsuchiya  | Nominee Director | 30-Jun-2020 | Current |
| Kazutaka Kanairo | Director | 04-Mar-2019 | Current |
Financial Performance and Corporate Structure Insights of Neuroglia Health.
Neuroglia Health Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.46% increase. The company also saw a substantial improvement in profitability, with a 42.09% increase in profit. The company's net worth Soared by an impressive increase of 60.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neuroglia Health?
In 2022, Neuroglia Health had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dr Bhatia Medical Coaching Institute Private LimitedActive 25 years 6 monthsKazutaka Kanairo and Vineet Bagri are mutual person
Dr.Bhatia E-Gurukul Coaching Institute Private LimitedActive 1 year 4 monthsKazutaka Kanairo and Vineet Bagri are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neuroglia Health?
Neuroglia Health has a workforce of 282 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neuroglia Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuroglia Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
